IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis

Baron, 2001, Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM, Neurology, 57, 1561, 10.1212/WNL.57.9.1561 Bartoccioni, 1994, Constitutive and cytokine-induced production of interleukin-6 by human myoblasts, Immunol. Lett., 42, 135, 10.1016/0165-2478(94)90076-0 Bartoccioni, 1994, MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies, Clin. Exp. Immunol., 95, 166, 10.1111/j.1365-2249.1994.tb06032.x Bartoccioni, 2003, IL-6, monocyte infiltration and parenchymal cells, Trends Immunol., 24, 299, 10.1016/S1471-4906(03)00112-1 Dalakas, 2002, Inflammatory myopathies. Recent advances in pathogenesis and therapy, Adv. Neurol., 88, 253 de Hooge, 2000, Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis, Am. J. Pathol., 157, 2081, 10.1016/S0002-9440(10)64846-8 De Rossi, 2000, Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation, Int. Immunol., 12, 1329, 10.1093/intimm/12.9.1329 Deng, 2002, Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production, J. Immunol., 169, 1077, 10.4049/jimmunol.169.2.1077 Eriksson, 2003, Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3, Circulation, 107, 320, 10.1161/01.CIR.0000043802.38699.66 Eugster, 1998, IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis, Eur. J. Immunol., 28, 2178, 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D Gallucci, 1998, Myoblasts produce IL-6 in response to inflammatory stimuli, Int. Immunol., 10, 267, 10.1093/intimm/10.3.267 Goletz, 1997, Delivery of antigens to the MHC class I pathway using bacterial toxins, Hum. Immunol., 54, 129, 10.1016/S0198-8859(97)00081-5 Hohlfeld, 1997, Cellular immune mechanisms in inflammatory myopathies, Curr. Opin. Rheumatol., 9, 520, 10.1097/00002281-199711000-00007 Hurst, 2001, IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation, Immunity, 14, 705, 10.1016/S1074-7613(01)00151-0 Jones, 2002, The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex, Biochim. Biophys. Acta, 1592, 251, 10.1016/S0167-4889(02)00319-1 Kaplanski, 2003, IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation, Trends Immunol., 24, 25, 10.1016/S1471-4906(02)00013-3 Klouche, 1999, Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor, J. Immunol., 163, 4583, 10.4049/jimmunol.163.8.4583 Kojima, 1997, Myosin-induced autoimmune polymyositis in the rat, J. Neurol. Sci., 151, 141, 10.1016/S0022-510X(97)00148-2 Kopf, 1994, Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, 368, 339, 10.1038/368339a0 Matsubara, 1993, Experimental allergic myositis in SJL/J mice immunized with rabbit myosin B fraction: immunohistochemical analysis and transfer, Acta Neuropathol., 85, 138, 10.1007/BF00227760 Mazzarelli, 1998, Effect of transforming growth factor-beta 1 on secretion of interleukin-6 in human myoblasts, J. Neuroimmunol., 87, 185, 10.1016/S0165-5728(98)00110-6 Mendel, 1998, IL-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice, Eur. J. Immunol., 28, 1727, 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-# Nemoto, 2003, Skeletal muscle myosin is the autoantigen for experimental autoimmune myositis, Exp. Mol. Pathol., 74, 238, 10.1016/S0014-4800(03)00003-0 Okuda, 1998, IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein, Int. Immunol., 10, 703, 10.1093/intimm/10.5.703 Romano, 1997, Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment, Immunity, 6, 315, 10.1016/S1074-7613(00)80334-9 Ryan, 1998, Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28, Int. Immunol., 10, 651, 10.1093/intimm/10.5.651 Samoilova, 1998, IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL6 in the activation and differentiation of autoreactive T cells, J. Immunol., 161, 6480, 10.4049/jimmunol.161.12.6480 Skuk, 2002, Experimental and therapeutic approaches to muscular dystrophies, Curr. Opin. Neurol., 15, 563, 10.1097/00019052-200210000-00007 Tidball, 2005, Inflammatory processes in muscle injury and repair, Am. J. Physiol., Regul. Integr. Comp. Physiol., 288, 345, 10.1152/ajpregu.00454.2004 Tidball, 2005, Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis, Curr. Opin. Rheumatol., 17, 707, 10.1097/01.bor.0000179948.65895.1a